Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and safety of non‐ergot dopamine‐receptor agonists as an adjunct to levodopa in advanced Parkinson's disease: A network meta‐analysis
Xiang‐Ting Chen, Qian Zhang, Siyuan Wen, et al.
European Journal of Neurology (2022) Vol. 30, Iss. 3, pp. 762-773
Open Access | Times Cited: 11

Showing 11 citing articles:

Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access | Times Cited: 2
Comparative efficacy and safety of adjunctive drugs to levodopa for fluctuating Parkinson’s disease - network meta-analysis
Wataru Sako, Yuki Kogo, Michinori Koebis, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Comparative safety signals of dopamine agonists: psychiatric and cardiovascular risks derived from FDA adverse event reporting system (FAERS) data
Mu Li, Jing Xu, Xiaomei Ye, et al.
BMC Pharmacology and Toxicology (2025) Vol. 26, Iss. 1
Open Access
Levodopa treatment: impacts and mechanisms throughout Parkinson’s disease progression
Peter Riederer, Sabrina Strobel, Toshiharu Nagatsu, et al.
Journal of Neural Transmission (2025)
Open Access
The Dopaminergic Cells in the Median Raphe Region Regulate Social Behavior in Male Mice
Tiago Chaves, Bibiána Török, Csilla Lea Fazekas, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4315-4315
Open Access | Times Cited: 3
The Role of the Dopaminergic Cells of the Median Raphe Region in the Behavior of the Male Mice
Tiago Chaves, Bibiána Török, Csilla Lea Fazekas, et al.
(2024)
Open Access | Times Cited: 2
The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson’s and Alzheimer’s Disease Progression
Rafael Franco, Claudia Garrigós, Jaume Lillo, et al.
Cells (2024) Vol. 13, Iss. 15, pp. 1288-1288
Open Access | Times Cited: 2
Comparative efficacy and safety of six non-ergot dopamine-receptor agonists in early Parkinson's disease: a systematic review and network meta-analysis
Xiang‐Ting Chen, Qian Zhang, Feifei Chen, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 6
The beta-sitosterol beta-D-glucoside (BSSG) rat model of Parkinson's disease
Raafat Soliman, Nourhan S. Sultan, Hagar Mostafa Lokman, et al.
Elsevier eBooks (2024), pp. 187-201
Closed Access
Comparative Pharmacokinetics and Bioequivalence Evaluation of Two Formulations of Pramipexole Dihydrochloride Extended-Release Tablets in Healthy Chinese Subjects Under Fasted and Fed States: A Randomized, Open-Label, Single-Dose, Two-Period Crossover Clinical Trial
Ling Yang, Liangliang Zhang, Zhu Luo
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 2369-2381
Open Access
Page 1

Scroll to top